KESIMPTA 20 MG/0.4 ML PEN

$24459.3000per ML

Strength

20 mg/.4mL

Manufacturer

NDC

00078100768

Classification

Brand

Dosage Form

INJECTION, SOLUTION

Route

SUBCUTANEOUS

Last Updated

1/7/2026

Active Ingredients

Approval Type

Biologic (BLA)

FDA Application

On Market Since

10/26/2009

Pharmacological Classes

CD20-directed Antibody Interactions

CD20-directed Cytolytic Antibody

0.0%

+8.2%

N/A

All

+16.1%

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.

Same classification

No related drugs found.